Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Non Operating Investment Income (2019 - 2020)

Updated

Emmaus Life Sciences' Non Operating Investment Income came in at $6.46 million for Q3 2020, compared with -$5.25 million a year earlier.

Analysis

Emmaus Life Sciences (EMMA) Non Operating Investment Income (2019 - 2020) Analysis & Trends

Over the trailing twelve months to Sep 30, 2020, Emmaus Life Sciences reported Non Operating Investment Income of -$2.48 million; for FY2019, it was -$21.95 million.

  • Going back by year, Non Operating Investment Income was -$43.98 million in FY2018.
  • The five-year range for quarterly Non Operating Investment Income is -$10.54 million (Q4 2019) to $6.84 million (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 6.46 Mn
Mar 31, 2020 6.84 Mn
Dec 31, 2019 -10.54 Mn
Sep 30, 2019 -5.25 Mn
Mar 31, 2019 -6.46 Mn
API Access

Emmaus Life Sciences Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=EMMA&period=max&api_key=YOUR_API_KEY